CASP8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.948000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.523600E-01
Normal-vs-Stage2
5.308400E-01
Normal-vs-Stage3
3.226200E-01
Normal-vs-Stage4
4.684600E-01
Stage1-vs-Stage2
3.884000E-01
Stage1-vs-Stage3
2.003800E-01
Stage1-vs-Stage4
5.452000E-01
Stage2-vs-Stage3
3.950400E-02
Stage2-vs-Stage4
9.058000E-01
Stage3-vs-Stage4
1.291200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.933400E-01
Normal-vs-AfricanAmerican
4.487600E-01
Normal-vs-Asian
5.505200E-01
Caucasian-vs-AfricanAmerican
6.154400E-01
Caucasian-vs-Asian
5.597600E-01
AfricanAmerican-vs-Asian
5.037200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.033200E-01
Normal-vs-Female
4.842800E-01
Male-vs-Female
6.184400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.929200E-01
Normal-vs-Age(41-60Yrs)
5.623200E-01
Normal-vs-Age(61-80Yrs)
4.699000E-01
Normal-vs-Age(81-100Yrs)
4.505200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.103400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.264800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.261200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.821700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.369900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.406800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.737000E-01
Normal-vs-Daily Drinker
4.392600E-01
Normal-vs-Weekly Drinker
4.899800E-01
Normal-vs-Occasional Drinker
5.258800E-01
Normal-vs-Social Drinker
5.089800E-01
Non Drinker-vs-Daily Drinker
5.701400E-01
Non Drinker-vs-Weekly Drinker
8.906800E-01
Non Drinker-vs-Occasional Drinker
5.248000E-01
Non Drinker-vs-Social Drinker
6.037800E-01
Daily Drinker-vs-Weekly Drinker
6.100000E-01
Daily Drinker-vs-Occasional Drinker
3.318400E-01
Daily Drinker-vs-Social Drinker
3.565800E-01
Weekly Drinker-vs-Occasional Drinker
7.368400E-01
Weekly Drinker-vs-Social Drinker
8.096400E-01
Occasional Drinker-vs-Social Drinker
8.769600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.201600E-01
Normal-vs-Grade 2
5.564300E-03
Normal-vs-Grade 3
3.863100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.917800E-03
Grade 1-vs-Grade 3
7.95890000000465E-05
Grade 1-vs-Grade 4
2.201600E-01
Grade 2-vs-Grade 3
9.014300E-02
Grade 2-vs-Grade 4
5.564300E-03
Grade 3-vs-Grade 4
3.863100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.588400E-01
Normal-vs-NonDiabetic
4.836600E-01
Diabetic-vs-NonDiabetic
5.600800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.088600E-01
Normal-vs-NoPancreatitis
4.796800E-01
Pancreatitis-vs-NoPancreatitis
7.251400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.492400E-01
Normal-vs-N1
5.215400E-01
N0-vs-N1
6.757900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.559400E-01
Normal-vs-TP53-NonMutant
4.832000E-01
TP53-Mutant-vs-TP53-NonMutant
3.721800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
